Tuesday, June 8, 2010

New Osteoporosis Medication Approved By FDA

The US Food and Drug Administration(FDA) recently approved the first drug in a new class of osteoporosis-fighting medications known as RANKL, or RANK ligand inhibitors. These medications work decrease bone loss in a way that is different from other osteoporosis medications (such as Fosamax, Boniva, etc.)

The newly approved drug, denosumab (Prolia), is an injectable medication derived from a synthetic antibody. It is approved by the FDA for treating postmenopausal women with osteoporosis and other patients who have failed or couldn't tolerate other medications.

To learn more, call 260-9322.

The Blogs I Read

All posts are copyright Musculoskeletal Imaging of Tulsa.